Volume 133, Issue S3 p. 8-9
Comment

Government funding of fluorodeoxyglucose positron emission tomography (FDG-PET) in rare urological cancers: better data, better outcomes

Jennifer Xu

Corresponding Author

Jennifer Xu

Department of Urology, Royal Melbourne Hospital, Parkville, Vic., Australia

Correspondence: Jennifer Xu, Department of Urology, Royal Melbourne Hospital, 300 Grattan Street, Parkville, Vic. 3050, Australia.

e-mail: [email protected]

Search for more papers by this author
Haidar Al Saffar

Haidar Al Saffar

Department of Uro-Oncology, Peter MacCallum Cancer Centre, Parkville, Vic., Australia

Search for more papers by this author
Jonathan O'Brien

Jonathan O'Brien

Department of Uro-Oncology, Peter MacCallum Cancer Centre, Parkville, Vic., Australia

Search for more papers by this author
Brian Kelly

Brian Kelly

Department of Uro-Oncology, Peter MacCallum Cancer Centre, Parkville, Vic., Australia

Search for more papers by this author
Nathan Lawrentschuk

Nathan Lawrentschuk

Department of Urology, Royal Melbourne Hospital, Parkville, Vic., Australia

Department of Uro-Oncology, Peter MacCallum Cancer Centre, Parkville, Vic., Australia

Search for more papers by this author
First published: 19 July 2023
No abstract is available for this article.